Histamine, Mast Cells, and Heart Failure. Is There a Connection?* * Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

Journal of the American College of Cardiology

Volumn 48, Issue 7, 2006, Pages 1385-1386

  Francis, Gary S ^a   Tang, W H Wilson ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FAMOTIDINE; HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H2 RECEPTOR; HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR; TEPRENONE;

DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; HEART FAILURE; HEART HEMODYNAMICS; HISTAMINE RELEASE; HUMAN; MAST CELL; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

CARDIAC OUTPUT, LOW; HISTAMINE; HISTAMINE H2 ANTAGONISTS; HUMANS; MAST CELLS; RECEPTORS, HISTAMINE H2; RENIN-ANGIOTENSIN SYSTEM;

EID: 33748935513     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.07.014     Document Type: Editorial

References (18)

1. Eckel L., Gristwood R.W., Nawrath H., Owen D.A., and Satter P. Inotropic and electrophysiological effects of histamine on human ventricular heart muscle. J Physiol 330 (1982) 111-123
2. Gantz I., Schaffer M., DelValle J., et al. Molecular cloning of a gene encoding the histamine H2 receptor. Proc Natl Acad Sci U S A 88 (1991) 5937
3. Le Coniat M., Traiffort E., Ruat M., Arrang J.M., and Berger R. Chromosomal localization of the human histamine H1-receptor gene. Hum Genet 94 (1994) 186-188
4. Lovenberg T.W., Roland B.L., Wilson S.J., et al. Cloning and functional expression of the human histamine H3 receptor. Mol Pharmacol 55 (1999) 1101-1107
5. Oda T., Morikawa N., Saito Y., Masuho Y., and Matsumoto S. Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. J Biol Chem 275 (2000) 36781-36786
6. Dvorak A.M. Mast-cell degranulation in human hearts. N Engl J Med 315 (1986) 969-970
7. Bristow M.R., Ginsburg R., and Harrison D.C. Histamine and the human heart: the other receptor system. Am J Cardiol 49 (1982) 249-251
8. Marone G., de Crescenzo G., Adt M., Patella V., Arbustini E., and Genovese A. Immunological characterization and functional importance of human heart mast cells. Immunopharmacology 31 (1995) 1-18
9. Hara M., Ono K., Hwang M.W., et al. Evidence for a role of mast cells in the evolution to congestive heart failure. J Exp Med 195 (2002) 375-381
10. Silver R.B., Reid A.C., Mackins C.J., et al. Mast cells: a unique source of renin. Proc Natl Acad Sci U S A 101 (2004) 13607-13612
11. Mackins C.J., Kano S., Seyedi N., et al. Cardiac mast cell-derived renin promotes local angiotensin formation, norepinephrine release, and arrhythmias in ischemia/reperfusion. J Clin Invest 116 (2006) 1063-1070
12. Hill S.J., Ganellin C.R., Timmerman H., et al. International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol Rev 49 (1997) 253-278
13. Wolff A.A., and Levi R. Histamine and cardiac arrhythmias. Circ Res 58 (1986) 1-16
14. Panizo A., Mindan F.J., Galindo M.F., Cenarruzabeitia E., Hernandez M., and Diez J. Are mast cells involved in hypertensive heart disease?. J Hypertens 13 (1995) 1201-1208
15. Greenberg B. Cardiac Remodeling: Mechanisms and Treatment. 1st edition (2006), Taylor and Francis Group, New York, NY
16. Asanuma H., Minamino T., Ogai A., et al. Blockade of histamine H(2) receptors protects the heart against ischemia and reperfusion injury in dogs. J Mol Cell Cardiol 40 (2006) 666-674
17. 2 receptors on chronic heart failure revealed by retrospective and prospective randomized studies. J Am Coll Cardiol 48 (2006) 1378-1384
18. Kim J., Washio T., and Yamagishi M. A novel data mining approach to the identification of effective drugs or combinations for targeted endpoints-application to chronic heart failure as a new form of evidence-based medicine. Cardiovasc Drugs Ther 18 (2004) 483-489